We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-6.34%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$57.8B
AUM Growth
-$2.88B
Cap. Flow
+$1.24B
Cap. Flow %
2.14%
Top 10 Hldgs %
45.42%
Holding
2,491
New
223
Increased
1,138
Reduced
765
Closed
178

Sector Composition

Rank Sector Weight
1 Technology 4.36%
2 Financials 2.9%
3 Consumer Discretionary 1.73%
4 Healthcare 1.64%
5 Consumer Staples 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRTA
2076
Strata Critical Medical Inc
SRTA
$436M
$73K ﹤0.01%
18,220
SGMO
2077
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$73K ﹤0.01%
14,979
+139
+0.9% +$714
GOOG icon
2078
PUT
Alphabet (Google) Class C
GOOG
$3.9T
$72K ﹤0.01%
6,000
+2,000
+50% +$223K
RVSB icon
2079
Riverview Bancorp
RVSB
$107M
$72K ﹤0.01%
11,263
-237
-2% -$1.63K
PSTX
2080
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$72K ﹤0.01%
20,304
BITS icon
2081
Global X Blockchain & Bitcoin Strategy ETF
BITS
$23.8M
$71K ﹤0.01%
2,619
CIG icon
2082
CEMIG Preferred Shares
CIG
$6.09B
$70K ﹤0.01%
45,223
-2,492
-5% -$4.29K
BSBR icon
2083
Santander
BSBR
$39.7B
$69K ﹤0.01%
+12,256
New +$68.8K
KGC icon
2084
Kinross Gold
KGC
$28.5B
$69K ﹤0.01%
18,391
+7,045
+62% +$23.9K
IGR
2085
CBRE Global Real Estate Income Fund
IGR
$712M
$67K ﹤0.01%
11,627
-3,944
-25% -$28.8K
MRKR icon
2086
Marker Therapeutics
MRKR
$20.3M
$67K ﹤0.01%
18,164
RKLB icon
2087
Rocket Lab Corp
RKLB
$39.9B
$67K ﹤0.01%
16,401
-42
-0.3% -$207
NOVN
2088
DELISTED
Novan, Inc. Common Stock
NOVN
$67K ﹤0.01%
36,025
CTOS icon
2089
Custom Truck One Source
CTOS
$2.47B
$66K ﹤0.01%
+11,239
New +$70.1K
UEC icon
2090
Uranium Energy
UEC
$4.71B
$66K ﹤0.01%
18,954
-10,334
-35% -$39.5K
AIRS icon
2091
AirSculpt Technologies
AIRS
$325M
$64K ﹤0.01%
10,000
DOUG icon
2092
Douglas Elliman
DOUG
$155M
$64K ﹤0.01%
16,325
-239
-1% -$1.18K
ITUB icon
2093
Itaú Unibanco
ITUB
$91.3B
$64K ﹤0.01%
13,956
+124
+0.9% +$529
OCUL icon
2094
Ocular Therapeutix
OCUL
$1.86B
$64K ﹤0.01%
+15,394
New +$77.5K
GRTS
2095
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$64K ﹤0.01%
24,950
EAR
2096
DELISTED
Eargo, Inc. Common Stock
EAR
$64K ﹤0.01%
3,033
+52
+2% +$1.4K
BLDP
2097
Ballard Power Systems
BLDP
$874M
$63K ﹤0.01%
+10,259
New +$76.7K
KPTI icon
2098
Karyopharm Therapeutics
KPTI
$168M
$63K ﹤0.01%
773
CORZ
2099
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$63K ﹤0.01%
48,269
-700
-1% -$1.49K
VXRT
2100
DELISTED
Vaxart
VXRT
$62K ﹤0.01%
28,501
+1
+0% +$3

Similar funds

Creative Planning's Q3 2022 Portfolio in Review

As of Q3 2022, Creative Planning held 2,491 positions worth $57.8B, down 4.8% from $60.7B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Creative Planning's Q3 2022 filing shows 223 new, 1,138 increased, 765 reduced and 178 closed positions. Its largest new stake was Greenlane Holdings: 4 shares worth $4.19M. The largest sale was iShares Core S&P 500 ETF, an estimated $168M.

By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 4.5% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Creative Planning's largest Q3 2022 buy was Greenlane Holdings: 4 shares worth $4.19M.
  • Creative Planning added most to Schwab US Large- Cap ETF in Q3 2022, an estimated $445M increase.
  • Creative Planning's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $168M.
  • Creative Planning fully exited BNY Mellon US Small Cap Core Equity ETF in Q3 2022, selling an estimated $16.3M.
  • Creative Planning's ten largest holdings make up 45% of its $57.8B portfolio in Q3 2022.
  • Creative Planning opened 223 new positions and closed 178 in Q3 2022.
  • Creative Planning's portfolio value fell 4.8% quarter-over-quarter to $57.8B.

Based on Creative Planning's 13F filing for Q3 2022, filed 3 Nov 2022.